Michael Morse

700 total citations
9 papers, 402 citations indexed

About

Michael Morse is a scholar working on Surgery, Neurology and Molecular Biology. According to data from OpenAlex, Michael Morse has authored 9 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 3 papers in Neurology and 2 papers in Molecular Biology. Recurrent topics in Michael Morse's work include Testicular diseases and treatments (4 papers), Neuroblastoma Research and Treatments (3 papers) and Renal cell carcinoma treatment (2 papers). Michael Morse is often cited by papers focused on Testicular diseases and treatments (4 papers), Neuroblastoma Research and Treatments (3 papers) and Renal cell carcinoma treatment (2 papers). Michael Morse collaborates with scholars based in United States, Canada and United Kingdom. Michael Morse's co-authors include Pramod C. Sogani, Harry W. Herr, William R. Fair, George J. Bosl, Robert J. Motzer, Nancy L. Geller, Joel Sheinfeld, Paul Russo, Willet F. Whitmore and Dean F. Bajorin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The American Journal of Medicine.

In The Last Decade

Michael Morse

9 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Morse United States	8	325	145	98	95	74	9	402
J Matośka Slovakia	11	191 0.6×	24 0.2×	103 1.1×	85 0.9×	71 1.0×	48	306
Maria Carolina Gelli Italy	11	146 0.4×	49 0.3×	54 0.6×	45 0.5×	31 0.4×	32	371
Mark Lyda United States	9	112 0.3×	40 0.3×	76 0.8×	85 0.9×	12 0.2×	10	392
Gülten Karpuzoğlu Türkiye	10	66 0.2×	19 0.1×	94 1.0×	44 0.5×	26 0.4×	29	303
Chris H. Jokinen United States	10	95 0.3×	72 0.5×	34 0.3×	36 0.4×	63 0.9×	13	288
Elisabeth A. McKeen United States	7	48 0.1×	56 0.4×	71 0.7×	82 0.9×	17 0.2×	10	369
Arun R. Chitale India	10	75 0.2×	67 0.5×	31 0.3×	64 0.7×	12 0.2×	21	340
J.-O. Bay France	10	39 0.1×	108 0.7×	78 0.8×	82 0.9×	6 0.1×	24	370
Kazuya Ariyoshi Japan	11	91 0.3×	24 0.2×	96 1.0×	95 1.0×	356 4.8×	34	629
Chunju Zhou China	10	41 0.1×	75 0.5×	93 0.9×	80 0.8×	7 0.1×	49	326

Countries citing papers authored by Michael Morse

Since Specialization

Citations

This map shows the geographic impact of Michael Morse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Morse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Morse more than expected).

Fields of papers citing papers by Michael Morse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Morse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Morse. The network helps show where Michael Morse may publish in the future.

Co-authorship network of co-authors of Michael Morse

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Morse. A scholar is included among the top collaborators of Michael Morse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Morse. Michael Morse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Le, Dung T., Andrea Wang‐Gillam, Vincent J. Picozzi, et al.. (2014). A phase 2, randomized trial of GVAX pancreas and CRS-207 immunotherapy versus GVAX alone in patients with metastatic pancreatic adenocarcinoma: Updated results.. Journal of Clinical Oncology. 32(3_suppl). 177–177. 25 indexed citations

Azizi, Behrooz, Thomas J. Whelan, & Michael Morse. (2009). Renal tumors and the risk of malignancy based on size.. PubMed. 16(6). 4921–3. 2 indexed citations

Whelan, Thomas J., et al.. (2006). Radical nephrectomy with en bloc resection of liver, diaphragm, and lung for locally invasive sarcomatoid renal cell carcinoma. Urology. 68(4). 890.e1–890.e4. 8 indexed citations

Heneghan, Michael A., Janet E. Tuttle‐Newhall, Paul V. Suhocki, et al.. (2003). De-Novo Cholangiocarcinoma in the Setting of Recurrent Primary Sclerosing Cholangitis Following Liver Transplant. American Journal of Transplantation. 3(5). 634–638. 18 indexed citations

Motzer, Robert J., Nancy L. Geller, Harry W. Herr, et al.. (1991). Salvage chemotherapy for patients with germ cell tumors. The memorial sloan-kettering cancer center experience (1979–1989). Cancer. 67(5). 1305–1310. 106 indexed citations

Motzer, Robert J., Nancy L. Geller, David G. Pfister, et al.. (1990). Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors. Cancer. 65(11). 2465–2470. 29 indexed citations

Motzer, Robert J., Nancy L. Geller, Dean F. Bajorin, et al.. (1990). The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors. Cancer. 66(12). 2476–2481. 88 indexed citations

Sheinfeld, Joel, Victor E. Reuter, Myron R. Melamed, et al.. (1990). Enhanced Bladder Cancer Detection with the Lewis X Antigen as a Marker of Neoplastic Transformation. The Journal of Urology. 143(2). 285–288. 81 indexed citations

Bosl, George J., Alan Yagoda, Robert B. Golbey, et al.. (1985). Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors. The American Journal of Medicine. 78(3). 423–428. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact